Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis.

Cardiovasc Diabetol · 2023 · PMC10612254 · PMID 37891550

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

Sotagliflozin users had a borderline significantly lower risk of CV death or HHF than dapagliflozin users with borderline significance (RR: 0.90, 95% CI 0.80–1.01) (Fig. 2 B).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.